NCT06112119 is a clinical trial of MSCT in Sepsis-Associated Encephalopathy, sponsored by Assiut University.

Who is sponsoring NCT06112119?

NCT06112119 is sponsored by Assiut University.

What drugs are being tested in NCT06112119?

Interventions in NCT06112119: MSCT.

What condition does NCT06112119 study?

NCT06112119 studies Sepsis-Associated Encephalopathy.

Is NCT06112119 still recruiting?

NCT06112119 is currently status unknown. Last updated 1 November 2023.

Last reviewed 2023-11-01 · How we verify

NCT06112119

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of MSCT Volumetry in Assessment of Brain Atrophy in Septic Patients

Status unknown Last updated 1 November 2023

What this trial tests

trial testing MSCT in Sepsis-Associated Encephalopathy in 55 participants. Status unknown.

Timeline

1 November 2023

Primary endpoint
1 November 2024

30 December 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	55
Start date	1 November 2023
Primary completion	1 November 2024
Estimated completion	30 December 2024

Drugs / interventions tested

MSCT

Conditions studied

Sepsis-Associated Encephalopathy — all drugs for Sepsis-Associated Encephalopathy →

Sponsor

Assiut University

Who can join

Adults 16 to 45, any sex, with Sepsis-Associated Encephalopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

assessment of brain atrophy associated with septic ICU patients by using MSCT Volumetry

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MSCT

Trials testing the same drug.

NCT05592457 — Role of Non-contrast MDCT in the Assessment of Upper Urinary Tract Calculi Post ESWL to Predict Its Success Rate · unknown
NCT04492865 — MSCT Chest in Suspected COVID-19 Patients · unknown
NCT03521011 — Non Enhanced MSCT In Diagnosis of Causes of Acute Abdomen Cases · completed

Other recruiting trials for Sepsis-Associated Encephalopathy

Currently open trials in the same condition.

NCT04230447 — Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE) · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06112119 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 1 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06112119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing